Over 1050 Cleansweep Auctions End Tomorrow 02/06 - Bid Now

Boston Scientific receives U.S. FDA approval for the Vercise Deep Brain Stimulation System

Press releases may be edited for formatting or style | December 12, 2017 Alzheimers/Neurology

*The Vercise™ Gevia™ DBS System is not available for use or sale in the U.S.

**Vercise Cartesia™ Directional Lead - Caution: Investigational Device. Limited by Federal (or U.S.) law to investigational use only. Not available for sale in the U.S.

References

1http://www.pdf.org/parkinson_statistics Accessed 04AUG2017.
2 Timmermann, Lars et al. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study. The Lancet Neurology, Volume 14, Issue 7, 693 - 701.
31.5 Tesla MR conditional when all conditions of use are met.

SOURCE Boston Scientific Corporation

Back to HCB News

You Must Be Logged In To Post A Comment